✦ LIBER ✦

Efficacy and safety of tacrolimus (TAC) vs. cyclosporine microemulsion (CME) in de novo cardiac transplant recipients: 6-month results

✍ Scribed by M Grimm; M Rinaldi; N.A Yonan

Book ID: 117710197
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 48 KB
Volume: 22
Category: Article
ISSN: 1557-3117
DOI: 10.1016/s1053-2498(02)00732-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of tacrolimus versus

Efficacy and safety of tacrolimus versus cyclosporine microemulsion in primary cardiac transplant recipients: 6-month results in Taiwan

✍ C.H. Wang; W.J. Ko; N.K. Chou; S.S. Wang 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 60 KB

12 month report of a 3 arm multicenter c

12 month report of a 3 arm multicenter comparison of Tacrolimus (TAC), MMF or TAC/Sirolimus(SRL) and steroids vs Cyclosporine microemulsion(CYA), MMF and steroids in de novo cardiac transplant recipients

✍ J.W. Kobashigawa; L.W. Miller; G.M. Felker; S.D. Russel; G.A. Ewald; M. Zucker; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 90 KB

12-month safety and efficacy of everolim

12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients

✍ Helio Tedesco-Silva Jr; Stefan Vitko; Julio Pascual; Josette Eris; John C. Magee 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 504 KB

Safety, tolerability, and efficacy of ev

Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results

✍ Gary Levy; Heinz Schmidli; Jeffrey Punch; Elizabeth Tuttle-Newhall; David Mayer; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

Everolimus is a macrolide immunosuppressive agent with known consistent absorption. In this double-blind study, we examined the safety and tolerability of everolimus vs. placebo in de novo liver transplant recipients. One hundred and nineteen liver allograft recipients were randomized to 1 of 4 grou

A randomized, prospective, multi-center

A randomized, prospective, multi-center comparison of tacrolimus, mycophenolate mofetil (MMF) and steroids vs. cyclosporine (modified usp), mmf and steroids vs tacrolimus, sirolimus and steroids in de novo cardiac transplant recipients - 6 month report

✍ J.A Kobashigawa; L Miller; S Russell; G Ewald; M Zucker; L Goldberg; H Eisen; D 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Everolimus with Optimized Cyclosporine D

Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6-Month Safety and Efficacy Results of Two Randomized Studies

✍ Stefan Vitko; Helio Tedesco; Josette Eris; Julio Pascual; John Whelchel; John C. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB